ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $17,000 | +41.7% | 179 | -14.4% | 0.00% | – |
Q3 2021 | $12,000 | +50.0% | 209 | +75.6% | 0.00% | – |
Q2 2021 | $8,000 | 0.0% | 119 | 0.0% | 0.00% | – |
Q1 2021 | $8,000 | 0.0% | 119 | +9.2% | 0.00% | – |
Q4 2020 | $8,000 | -66.7% | 109 | -65.7% | 0.00% | – |
Q3 2020 | $24,000 | +100.0% | 318 | +12.4% | 0.00% | – |
Q2 2020 | $12,000 | 0.0% | 283 | 0.0% | 0.00% | – |
Q1 2020 | $12,000 | -7.7% | 283 | 0.0% | 0.00% | – |
Q4 2019 | $13,000 | -7.1% | 283 | -10.2% | 0.00% | – |
Q3 2019 | $14,000 | -22.2% | 315 | 0.0% | 0.00% | – |
Q2 2019 | $18,000 | +28.6% | 315 | 0.0% | 0.00% | – |
Q1 2019 | $14,000 | 0.0% | 315 | -14.2% | 0.00% | – |
Q4 2018 | $14,000 | +40.0% | 367 | +69.1% | 0.00% | – |
Q3 2018 | $10,000 | +11.1% | 217 | 0.0% | 0.00% | – |
Q2 2018 | $9,000 | 0.0% | 217 | 0.0% | 0.00% | – |
Q1 2018 | $9,000 | – | 217 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |